Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs standard-dose quadrivalent influenza vaccine in Japanese elderly
NCT04498832Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine in influenza, sponsored by Sanofi. Started Oct 2020; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04498832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04498832.